John T. Maxwell
2020
In 2020, John T. Maxwell earned a total compensation of $1.3M as Chief Financial Officer at Aquestive Therapeutics, a 24% increase compared to previous year.
Compensation breakdown
| Option Awards | $69,164 |
|---|---|
| Salary | $395,000 |
| Other | $847,106 |
| Total | $1,311,270 |
Maxwell received $847.1K in other compensation, accounting for 65% of the total pay in 2020.
Maxwell also received $69.2K in option awards and $395K in salary.
Rankings
In 2020, John T. Maxwell's compensation ranked 7,433rd out of 13,090 executives tracked by ExecPay. In other words, Maxwell earned more than 43.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,433 out of 13,090 | 43rd |
Division Manufacturing | 3,122 out of 5,621 | 45th |
Major group Chemicals And Allied Products | 1,260 out of 2,254 | 44th |
Industry group Drugs | 1,089 out of 1,954 | 44th |
Industry Pharmaceutical Preparations | 812 out of 1,459 | 44th |
Source: SEC filing on May 5, 2021.
Maxwell's colleagues
We found two more compensation records of executives who worked with John T. Maxwell at Aquestive Therapeutics in 2020.